Published in Biophys J on May 13, 2005
An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor. Blood (2005) 1.50
Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation. Proc Natl Acad Sci U S A (2013) 0.99
Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides. Proc Natl Acad Sci U S A (2013) 0.92
Lipid-protein correlations in nanoscale phospholipid bilayers determined by solid-state nuclear magnetic resonance. Biochemistry (2010) 0.83
His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor. J Biol Chem (2015) 0.83
Coupling of transmembrane helix orientation to membrane release of the juxtamembrane region in FGFR3. Biochemistry (2014) 0.77
A transmembrane helix dimer: structure and implications. Science (1997) 6.46
Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (1990) 4.59
Helix to helix packing in proteins. J Mol Biol (1981) 4.24
Sequence specificity in the dimerization of transmembrane alpha-helices. Biochemistry (1992) 4.19
SIMPSON: a general simulation program for solid-state NMR spectroscopy. J Magn Reson (2000) 4.04
Helical membrane protein folding, stability, and evolution. Annu Rev Biochem (2000) 3.63
TOXCAT: a measure of transmembrane helix association in a biological membrane. Proc Natl Acad Sci U S A (1999) 2.76
Polarized infrared spectroscopy of oriented purple membrane. Biophys J (1979) 2.60
Molecular biology of Friend viral erythroleukemia. Curr Top Microbiol Immunol (1989) 2.52
Helix packing in polytopic membrane proteins: role of glycine in transmembrane helix association. Biophys J (1999) 2.49
Helix packing in membrane proteins. J Mol Biol (1997) 2.47
Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc Natl Acad Sci U S A (1990) 2.23
Internal packing of helical membrane proteins. Proc Natl Acad Sci U S A (2000) 2.12
The structure of the omegaform of poly-Beta-benzyl-L-aspartate. J Mol Biol (1962) 1.91
Comparison of helix interactions in membrane and soluble alpha-bundle proteins. Biophys J (2002) 1.88
Envelope gene of the Friend spleen focus-forming virus: deletion and insertions in 3' gp70/p15E-encoding region have resulted in unique features in the primary structure of its protein product. Proc Natl Acad Sci U S A (1983) 1.87
Improved prediction for the structure of the dimeric transmembrane domain of glycophorin A obtained through global searching. Proteins (1996) 1.75
The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol Cell (2001) 1.72
Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line. J Virol (1990) 1.66
Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu Rev Cell Dev Biol (1996) 1.53
A heptad motif of leucine residues found in membrane proteins can drive self-assembly of artificial transmembrane segments. J Biol Chem (1999) 1.44
Orientation of the infrared transition moments for an alpha-helix. Biophys J (2000) 1.42
Characterization of leucine side-chain reorientation in collagen-fibrils by solid-state 2H NMR. Proc Natl Acad Sci U S A (1982) 1.36
Implications of threonine hydrogen bonding in the glycophorin A transmembrane helix dimer. Biophys J (2002) 1.34
Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc Natl Acad Sci U S A (1990) 1.33
Structure and orientation of the transmembrane domain of glycophorin A in lipid bilayers. Biochemistry (1994) 1.28
Disulfide bonding controls the processing of retroviral envelope glycoproteins. J Biol Chem (1991) 1.27
Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth. Proc Natl Acad Sci U S A (1989) 1.23
The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion. Mol Biol Cell (1999) 1.19
De novo design of conformationally flexible transmembrane peptides driving membrane fusion. Proc Natl Acad Sci U S A (2004) 1.14
Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells). Cross-linking of erythropoietin with the spleen focus-forming virus envelope protein. J Biol Chem (1991) 1.12
Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J Biol Chem (1993) 1.07
Env-derived gp55 gene of Friend spleen focus-forming virus specifically induces neoplastic proliferation of erythroid progenitor cells. EMBO J (1990) 1.02
Biological and biochemical differences between variants of spleen focus-forming virus can be localized to a region containing the 3' end of the envelope gene. J Virol (1985) 1.01
Role of side-chain conformational entropy in transmembrane helix dimerization of glycophorin A. Biophys J (2003) 1.00
Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain. EMBO J (1999) 0.95
Conversion of Friend mink cell focus-forming virus to Friend spleen focus-forming virus by modification of the 3' half of the env gene. J Virol (1991) 0.92
Genetic selection for and molecular dynamic modeling of a protein transmembrane domain multimerization motif from a random Escherichia coli genomic library. J Mol Biol (2001) 0.91
The erythropoietin receptor transmembrane domain mediates complex formation with viral anemic and polycythemic gp55 proteins. J Biol Chem (2003) 0.91
Fusion of the erythropoietin receptor and the Friend spleen focus-forming virus gp55 glycoprotein transforms a factor-dependent hematopoietic cell line. Mol Cell Biol (1993) 0.91
Val(659)-->Glu mutation within the transmembrane domain of ErbB-2: effects measured by (2)H NMR in fluid phospholipid bilayers. Biochemistry (2000) 0.87
Infrared dichroism from the X-ray structure of bacteriorhodopsin. Biophys J (2001) 0.86
Cell surface activation of the erythropoietin receptor by Friend spleen focus-forming virus gp55. J Virol (1995) 0.86
The hydrophobic membrane-spanning sequences of the gp52 glycoprotein are required for the pathogenicity of Friend spleen focus-forming virus. J Virol (1991) 0.86
Solid-state NMR studies of proteins: the view from static 2H NMR experiments. Biochem Cell Biol (1998) 0.83
Role of the transmembrane sequence of spleen focus-forming virus gp55 in erythroleukemogenesis. Virology (1998) 0.82
The interaction of the erythropoietin receptor and gp55. Cancer Surv (1992) 0.81
Selectable retrovirus vectors encoding Friend virus gp55 or erythropoietin induce polycythemia with different phenotypic expression and disease progression. J Virol (1994) 0.80
The anemic Friend virus gp55 envelope protein induces erythroid differentiation in fetal liver colony-forming units-erythroid. Blood (1998) 0.79
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature (2005) 18.43
Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res (2003) 14.79
Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat Struct Mol Biol (2010) 3.75
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med (2008) 3.24
Electrostatic sequestration of PIP2 on phospholipid membranes by basic/aromatic regions of proteins. Biophys J (2004) 2.66
NetPath: a public resource of curated signal transduction pathways. Genome Biol (2010) 2.62
New mutations and pathogenesis of myeloproliferative neoplasms. Blood (2011) 2.53
JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies. Semin Cell Dev Biol (2008) 2.37
Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation. Nat Struct Mol Biol (2009) 2.32
Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42. Biochemistry (2006) 1.88
Comparison of helix interactions in membrane and soluble alpha-bundle proteins. Biophys J (2002) 1.88
Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. Mol Cell (2003) 1.84
Multiple switches in G protein-coupled receptor activation. Trends Pharmacol Sci (2009) 1.83
Definition of an inhibitory juxtamembrane WW-like domain in the platelet-derived growth factor beta receptor. J Biol Chem (2002) 1.75
JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor. J Biol Chem (2005) 1.74
Location of Trp265 in metarhodopsin II: implications for the activation mechanism of the visual receptor rhodopsin. J Mol Biol (2006) 1.69
An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family. J Gen Physiol (2005) 1.64
Interaction of small molecule inhibitors of HIV-1 entry with CCR5. Virology (2006) 1.59
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes. Blood (2012) 1.59
An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia. J Exp Med (2009) 1.58
Coupling of retinal isomerization to the activation of rhodopsin. Proc Natl Acad Sci U S A (2004) 1.57
Activating mutations in human acute megakaryoblastic leukemia. Blood (2008) 1.56
High-resolution atomic force microscopy of soluble Abeta42 oligomers. J Mol Biol (2006) 1.55
Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs. J Biol Chem (2008) 1.54
Helix packing moments reveal diversity and conservation in membrane protein structure. J Mol Biol (2004) 1.53
Changes in interhelical hydrogen bonding upon rhodopsin activation. J Mol Biol (2005) 1.51
Binding of peptides with basic and aromatic residues to bilayer membranes: phenylalanine in the myristoylated alanine-rich C kinase substrate effector domain penetrates into the hydrophobic core of the bilayer. J Biol Chem (2003) 1.51
An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor. Blood (2005) 1.50
Location of the retinal chromophore in the activated state of rhodopsin*. J Biol Chem (2009) 1.48
Janus kinases affect thrombopoietin receptor cell surface localization and stability. J Biol Chem (2005) 1.41
miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Blood (2010) 1.41
Implications of threonine hydrogen bonding in the glycophorin A transmembrane helix dimer. Biophys J (2002) 1.34
A helix-to-coil transition at the epsilon-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis. Proc Natl Acad Sci U S A (2009) 1.30
The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood (2007) 1.27
Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity. J Biol Chem (2012) 1.26
Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2. J Biol Chem (2008) 1.20
A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation. PLoS Biol (2010) 1.14
Highly conserved tyrosine stabilizes the active state of rhodopsin. Proc Natl Acad Sci U S A (2010) 1.13
Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors. Haematologica (2011) 1.12
A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseases. Hematology Am Soc Hematol Educ Program (2005) 1.11
Structure of the membrane reconstituted transmembrane-juxtamembrane peptide EGFR(622-660) and its interaction with Ca2+/calmodulin. Biochemistry (2006) 1.10
Dipolar assisted rotational resonance NMR of tryptophan and tyrosine in rhodopsin. J Biomol NMR (2004) 1.09
Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor. Blood (2009) 1.08
A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects. Trends Mol Med (2005) 1.08
Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers. J Biol Chem (2009) 1.07
Microarray analysis of LIF/Stat3 transcriptional targets in embryonic stem cells. Stem Cells (2005) 1.05
Comparison of class A and D G protein-coupled receptors: common features in structure and activation. Biochemistry (2005) 1.05
JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors. PLoS One (2010) 1.04
Role of group-conserved residues in the helical core of beta2-adrenergic receptor. Proc Natl Acad Sci U S A (2007) 1.02
Light activation of rhodopsin: insights from molecular dynamics simulations guided by solid-state NMR distance restraints. J Mol Biol (2009) 1.01
Structural role of glycine in amyloid fibrils formed from transmembrane alpha-helices. Biochemistry (2005) 1.00
Role of side-chain conformational entropy in transmembrane helix dimerization of glycophorin A. Biophys J (2003) 1.00
Degradation of amyloid beta protein by purified myelin basic protein. J Biol Chem (2009) 1.00
Structure and function of G protein-coupled receptors using NMR spectroscopy. Prog Nucl Magn Reson Spectrosc (2010) 1.00
FLT3-ITDs instruct a myeloid differentiation and transformation bias in lymphomyeloid multipotent progenitors. Cell Rep (2013) 0.99
Role of tyrosine kinases and phosphatases in polycythemia vera. Semin Hematol (2005) 0.99
Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif. J Biol Chem (2008) 0.99
EGFR juxtamembrane domain, membranes, and calmodulin: kinetics of their interaction. Biophys J (2009) 0.99
Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation. Proc Natl Acad Sci U S A (2013) 0.99
Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors. Blood (2014) 0.98
Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors. J Biol Chem (2005) 0.96
Mechanism of penetration of Antp(43-58) into membrane bilayers. Biochemistry (2005) 0.96
Orientation-specific signalling by thrombopoietin receptor dimers. EMBO J (2011) 0.95
Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms. J Cell Mol Med (2013) 0.95
Aromatic residues at the extracellular ends of transmembrane domains 5 and 6 promote ligand activation of the G protein-coupled alpha-factor receptor. Biochemistry (2003) 0.95
A highly redundant gene network controls assembly of the outer spore wall in S. cerevisiae. PLoS Genet (2013) 0.94
Structural requirements of the extracellular to transmembrane domain junction for erythropoietin receptor function. J Biol Chem (2005) 0.93
Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides. Proc Natl Acad Sci U S A (2013) 0.92
Magic angle spinning nuclear magnetic resonance of isotopically labeled rhodopsin. Methods Enzymol (2002) 0.92
High-resolution 1H MAS RFDR NMR of biological membranes. J Magn Reson (2008) 0.92
Myelin basic protein binds to and inhibits the fibrillar assembly of Abeta42 in vitro. Biochemistry (2009) 0.91
Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain. J Biol Chem (2008) 0.90
NMR spectroscopy of phosphorylated wild-type rhodopsin: mobility of the phosphorylated C-terminus of rhodopsin in the dark and upon light activation. Biochemistry (2004) 0.90
What is the role of amyloid precursor protein dimerization? Cell Adh Migr (2010) 0.90
Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors. J Cell Mol Med (2013) 0.90
SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases. Haematologica (2009) 0.89
Impact of isolated germline JAK2V617I mutation on human hematopoiesis. Blood (2013) 0.89
N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly. J Biol Chem (2010) 0.88
Retinitis pigmentosa mutants provide insight into the role of the N-terminal cap in rhodopsin folding, structure, and function. J Biol Chem (2013) 0.88
A novel Src homology 2 domain-containing molecule, Src-like adapter protein-2 (SLAP-2), which negatively regulates T cell receptor signaling. J Biol Chem (2002) 0.88
Structural constraints on the transmembrane and juxtamembrane regions of the phospholamban pentamer in membrane bilayers: Gln29 and Leu52. Biochim Biophys Acta (2007) 0.88
Inhibition of familial cerebral amyloid angiopathy mutant amyloid beta-protein fibril assembly by myelin basic protein. J Biol Chem (2007) 0.87
High-throughput gateway bicistronic retroviral vectors for stable expression in mammalian cells: exploring the biologic effects of STAT5 overexpression. DNA Cell Biol (2004) 0.87